Research Article
Antimicrobial activity, cytotoxicity and inflammatory response of novel plastics embedded with silver nanoparticles
Published Online:6 Mar 2013https://doi.org/10.2217/fmb.13.5
Abstract
Aim: Infections associated with medical devices are an important cause of morbidity and mortality. Microorganisms are responsible for catheter infections that may then result in the local or systemic dissemination of the microorganism into the bloodstream. The aim of this study was to evaluate the antimicrobial activity of silver nanoparticles (AgNPs) embedded in polyurethane plastics, commonly used for catheter fabrication. Materials & methods: AgNPs in the range of 25–30 nm were synthesized and embedded in polyurethane plastics at different concentrations. The antimicrobial activities of these plastics were tested against the three pathogenic microorganisms, Escherichia coli, Staphylococcus epidermidis and Candida albicans, frequently associated with catheter infections. The cytotoxicity of the plastics was evaluated on human-derived macrophages using propidium iodide and the secretion of the pro- and anti-inflammatory cytokines IL-6, IL-10 and TNF-a was measured using ELISA. Results: A significant reduction of 6- to 7-log in the number of bacteria was measured, while a reduction of 90% was measured in the case of C. albicans. Neither cytotoxic effect on macrophages nor immunological response was observed. Conclusion: Plastics embedded with AgNPs have great potential to limit microbial colonization of implanted medical devices.
Keywords:
References
- 1 Coello R, Charlett A, Ward V et al. Device-related sources of bacteraemia in English hospitals – opportunities for the prevention of hospital-acquired bacteraemia. J. Hosp. Infect.53(1),46–57 (2003).
- 2 Lynch AS, Abbanat D. New antibiotic agents and approaches to treat biofilm-associated infections. Expert Opin. Ther. Pat.20(10),1373–1387 (2010).
- 3 Snaterse M, Ruger W, Scholte OP, Reimer WJ, Lucas C. Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J. Hosp. Infect.75(1),1–11 (2010).
- 4 Sirvent JM, Vidaur L, Garcia M et al. Colonization of the medial lumen is a risk factor for catheter-related bloodstream infection. Intensive Care Med.32(9),1404–1408 (2006).
- 5 Labeau SO, Vandijck DM, Rello J et al. Centers for Disease Control and Prevention guidelines for preventing central venous catheter-related infection: results of a knowledge test among 3405 European intensive care nurses. Crit. Care Med.37(1),320–323 (2009).
- 6 Walz JM, Memtsoudis SG, Heard SO. Prevention of central venous catheter bloodstream infections. J. Intensive Care Med.25(3),131–138 (2010).
- 7 Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med.30(1),62–67 (2004).
- 8 Garland JS, Alex CP, Sevallius JM et al. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters. Infect. Control Hosp. Epidemiol.29(3),243–249 (2008).
- 9 Martínez-Gutiérrez F, Olive PL, Banuelos A et al. Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles. Nanomedicine6(5),681–688 (2010).
- 10 Martínez-Gutiérrez F, Thi EP, Silverman JM et al. Antibacterial activity, inflammatory response, coagulation and cytotoxicity effects of silver nanoparticles. Nanomedicine8(3),328–336 (2012).
- 11 Lok CN, Ho CM, Chen R et al. Silver nanoparticles: partial oxidation and antibacterial activities. J. Biol. Inorg. Chem.12(4),527–534 (2007).
- 12 Morones JR, Elechiguerra JL, Camacho A et al. The bactericidal effect of silver nanoparticles. Nanotechnology16(10),2346–2353 (2005).
- 13 Zolnik BS, Gonzalez-Fernandez A, Sadrieh N, Dobrovolskaia MA. Nanoparticles and the immune system. Endocrinology151(2),458–465 (2010).
- 14 Gilbert RE, Harden M. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review. Curr. Opin. Infect. Dis.21(3),235–245 (2008).
- 15 Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J. Biomed. Mater. Res.52(4),662–668 (2000).
- 16 Matsumura Y, Yoshikata K, Kunisaki S, Tsuchido T. Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate. Appl. Environ. Microbiol.69(7),4278–4281 (2003).
- 17 Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J. Colloid Interface Sci.275(1),177–182 (2004).
- 18 Bell RA, Kramer JR. Structural chemistry and geochemistry of silver-sulfur compound: critical review. Environ. Toxicol. Chem.19,9–22 (1999).
- 19 Di Bernardo P, Dolcetti G, Portanova R et al. Thermodynamic and spectroscopic studies on silver(I) complex formation with phosphorous multidentate ligands in dimethyl sulfoxide. Inorg. Chem.29,2858–2862 (1990).
- 20 Kim S, Choi JE, Choi J et al. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol. In Vitro23(6),1076–1084 (2009).
- 21 Elechiguerra JL, Burt JL, Morones JR et al. Interaction of silver nanoparticles with HIV-1. J. Nanobiotechnology3,6 (2005).
- 22 Hackenberg S, Scherzed A, Kessler M et al. Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol. Lett.201(1),27–33 (2011).
- 23 Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect. Dis.7(10),645–657 (2007).
- 24 Takashiba S, Van Dyke TE, Amar S et al. Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmatic nuclear factor κB. Infect. Immun.67(11),5573–5578 (1999).
- 25 Pick N, Cameron S, Arad D, Av-Gay Y. Screening of compounds toxicity against human monocytic cell line-THP-1 by flow cytometry. Biol. Proced. Online6,220–225 (2004).
- 26 Hsu SH, Tseng HJ, Lin YC. The biocompatibility and antibacterial properties of waterborne polyurethane-silver nanocomposites. Biomaterials31(26),6796–6808 (2010).
- 27 Chou CW, Hsu S, Wang PH. Biostability and biocompatibility of poly(ether)urethane containing gold or silver nanoparticles in porcine model. J. Biomed. Mater. Res. A84,785–794 (2008).
- 28 Mermel LA, Farr BM, Sherertz RJ et al. Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis.32(9),1249–1272 (2001).
- 29 Lin JJ, Lin WC, Dong RX, Hsu SH. The cellular responses and antibacterial activities of silver nanoparticles stabilized by different polymers. Nanotechnology23(6),065102 (2012).
- 30 Trickler WJ, Lantz SM, Murdock RC et al. Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol. Sci.118(1),160–170 (2010).
- 31 Samberg ME, Oldenburg SJ, Monteiro-Riviere NA. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ. Health Perspect.118(3),407–413 (2010).
- 32 Alissawi N, Zaporojtchenko V, Strunskus T et al. Tuning of the ion release properties of silver nanoparticles buried under a hydrophobic polymer barrier. J. Nanopart. Res.14,928–940 (2012).
- 33 Fortunati E, Latterini L, Rinaldi S, Kenny JM, Armentano I. PLGA/Ag nanocomposites: in vitro degradation study and silver ion release. J. Mater. Sci. Mater. Med.22(12),2735–2744 (2011).
